当前位置:
X-MOL 学术
›
Nat. Rev. Endocrinol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Limiting the use and misuse of liothyronine in hypothyroidism
Nature Reviews Endocrinology ( IF 31.0 ) Pub Date : 2024-10-24 , DOI: 10.1038/s41574-024-01055-y Laszlo Hegedüs, Endre Vezekenyi Nagy, Enrico Papini, Petros Perros
Nature Reviews Endocrinology ( IF 31.0 ) Pub Date : 2024-10-24 , DOI: 10.1038/s41574-024-01055-y Laszlo Hegedüs, Endre Vezekenyi Nagy, Enrico Papini, Petros Perros
Liothyronine treatment for some patients with hypothyroidism has preoccupied academics, clinicians and patients for decades, and is a controversial topic in thyroidology. Persistent symptoms are at the heart of this discourse and, contrary to scientific evidence, liothyronine use is increasingly common. Aetiologies and interventions beyond thyroid dysregulation and pharmacological approaches must be pursued.
中文翻译:
限制碘塞罗宁在甲状腺功能减退症中的使用和误用
几十年来,碘塞罗宁治疗一些甲状腺功能减退症患者一直困扰着学者、临床医生和患者,是甲状腺学中一个有争议的话题。持续的症状是这种话语的核心,与科学证据相反,碘塞罗宁的使用越来越普遍。必须寻求甲状腺失调和药物方法以外的病因和干预措施。
更新日期:2024-10-25
中文翻译:
限制碘塞罗宁在甲状腺功能减退症中的使用和误用
几十年来,碘塞罗宁治疗一些甲状腺功能减退症患者一直困扰着学者、临床医生和患者,是甲状腺学中一个有争议的话题。持续的症状是这种话语的核心,与科学证据相反,碘塞罗宁的使用越来越普遍。必须寻求甲状腺失调和药物方法以外的病因和干预措施。